Clinical Trial

Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)

Study acronym: GoT
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 7, 2024 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Intensive Lipid-Lowering Therapy guided by a cloud-based Software System (CLIMEDO GmbH) improves (European Society of Cardiolofgy/European Atherosclerosis Society) ESC/EAS-guideline recommended LDL-cholesterol target attainment and adherence in patients with ST-Elevation Myocardial (STEMI) and Non-ST-Elevation Myocardial Infarctions (NSTEMI).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-10-17.
Status change: Recruiting → Not Yet Recruiting 2024-03-05
Trial Details
NCT Number NCT05587621
Lead Sponsor Jena University Hospital
Conditions ST Elevation Myocardial Infarction, Non-ST Elevation Myocardial Infarction, LDL-cholesterol
Enrollment 300 participants
Start Date 2024-04-01
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-03-07